HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific

scientific article published on 07 May 2018

HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GLIA.23447
P932PMC publication ID6185750
P698PubMed publication ID29733459

P50authorWolfgang J StreitQ88588846
P2093author name stringHabibeh Khoshbouei
Jay P McLaughlin
Joyonna Gamble-George
Fatemeh Shaerzadeh
Douglas R Miller
Leah Phan
Nesrin Sharif
P2860cites workDopamine neuron systems in the brain: an updateQ22251429
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Genome-wide atlas of gene expression in the adult mouse brainQ26253934
Bidirectional microglia-neuron communication in the healthy brainQ27024873
Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membraneQ27334784
Staging of brain pathology related to sporadic Parkinson's diseaseQ28131702
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cellsQ28144137
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1Q28510145
Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learningQ28579657
Ageing and Parkinson's disease: substantia nigra regional selectivityQ29615835
Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.Q30374429
Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat.Q30410538
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbensQ30856847
Dopamine in motor cortex is necessary for skill learning and synaptic plasticityQ30873734
Reactive microgliosisQ33604483
Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease.Q33633995
Microglial-neuronal interactions in synaptic damage and recoveryQ33734822
AMPA/kainate, NMDA, and dopamine D1 receptor function in the nucleus accumbens core: a context-limited role in the encoding and consolidation of instrumental memoryQ33841517
HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cellsQ34017780
Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firingQ34070426
HIV dementia: the role of the basal ganglia and dopaminergic systemsQ34098768
Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementiaQ34196506
The control of firing pattern in nigral dopamine neurons: single spike firingQ34248461
Involvement of dopamine in the progression of AIDS Dementia ComplexQ34603500
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.Q34609614
Doxycycline increases neurogenesis and reduces microglia in the adult hippocampusQ34654816
HIV-1 Tat protein increases microglial outward K(+) current and resultant neurotoxic activityQ34758981
Microglia as neuroprotective, immunocompetent cells of the CNS.Q34963638
Microglia in human immunodeficiency virus-associated neurodegeneration.Q34963796
Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposureQ35172603
Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and DoxycyclineQ35749130
ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo.Q36382599
Multiplexed neurochemical signaling by neurons of the ventral tegmental area.Q36759399
Age-related changes in rostral basal forebrain cholinergic and GABAergic projection neurons: relationship with spatial impairmentQ36784073
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's diseaseQ36947501
Neuroimmunity, drugs of abuse, and neuroAIDS.Q37015388
The brain-stem lesions in ParkinsonismQ37272987
Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic miceQ37301018
Methamphetamine Regulation of Firing Activity of Dopamine NeuronsQ37310335
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineQ37343442
Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapyQ37395461
Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?Q37764485
Microglia and intractable chronic painQ38022210
Selective dysfunction of basal ganglia subterritories: From movement to behavioral disordersQ38378640
Positive emotions and brain reward circuits in chronic painQ38703803
Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS.Q40497318
Microglial-neuronal interactionsQ40858481
Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's diseaseQ40870408
Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase geneQ41832311
Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cellsQ41843416
Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive functionQ41974621
Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brainQ42239439
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brainQ42477525
Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brainQ42518440
Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's diseaseQ43216888
The midbrain dopaminergic system: anatomy and genetic variation in dopamine neuron number of inbred mouse strainsQ43723860
The AIDS dementia complex: I. Clinical featuresQ43769670
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.Q44850278
Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.Q44949048
Differential effects of nicotine on the activity of substantia nigra and ventral tegmental area dopaminergic neurons in vitro.Q45058079
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlationsQ45302799
Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brainsQ45383832
Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.Q46110293
Dopamine and noradrenaline control distinct functions in rodent microglial cells.Q46467964
Glia cell number modulates sensitivity to MPTP in miceQ46514011
Minocycline does not inhibit microglia proliferation or neuronal regeneration in the facial nucleus following crush injuryQ46554757
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson modelQ46588473
Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autismQ46846718
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.Q47109201
Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's diseaseQ47916847
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment depositsQ48101192
Response of endogenous glial cells to motor neuron degeneration induced by toxic ricinQ48112674
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's diseaseQ48147372
Biochemical pathophysiology of Parkinson's disease.Q48258284
Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and humanQ48286913
HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvementQ48343313
Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adultQ48424044
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.Q48447568
Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivoQ48546483
l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's diseaseQ48655699
A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouseQ48887515
Cellular localization of brain monoaminesQ51297528
Cognitive dysfunction in HIV patients despite long-standing suppression of viremiaQ58074796
Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusionQ67944540
Nigral degeneration in acquired immune deficiency syndrome (AIDS)Q68057318
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's diseaseQ69378386
Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegenerationQ71323742
Control of posture in patients with neurologically asymptomatic HIV infection and patients with beginning HIV-1-related encephalopathyQ72871480
Neuronal damage of the substantia nigra in HIV-1 infected brainsQ73727349
Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regenerationQ73911879
The subpopulation of microglia sensitive to neurotransmitters/neurohormones is modulated by stimulation with LPS, interferon-γ, and IL-4Q87248985
P433issue9
P921main subjectneurologyQ83042
microgliaQ1622829
P304page(s)1915-1928
P577publication date2018-05-07
P1433published inGliaQ15716658
P1476titleHIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific
P478volume66

Reverse relations

Q91803186Microglia senescence occurs in both substantia nigra and ventral tegmental areacites workP2860

Search more.